Skip to main navigation
 logo

Content

Top Menu

  • Contact Us
  • About Novelion
    • Leadership Team
    • News
    • Aegerion Pharmaceuticals
  • Products & Pipeline
  • Physician Resources
    • Global Medical Information
    • Expanded Access Program
    • Clinical Programs
    • Grants & IIS
    • EU Payment Disclosures
  • Careers
    • Employee Voices
    • Apply Online
  • Investors

    Investor Relations

    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • SEDAR Filings
      • SEDI Filings
      • Annual Reports and Proxies
      • Key Ratios
      • 8937-original
      • 8937-amended
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
      • Ownership Profile
    • Shareholder Services
      • Investor FAQs
      • 2016 PFIC Letter
      • Aralez Distribution Form 8937
      • Contact Us
  • About Novelion
    • Leadership Team
    • News
    • Aegerion Pharmaceuticals
  • Products & Pipeline
  • Physician Resources
    • Global Medical Information
    • Expanded Access Program
    • Clinical Programs
    • Grants & IIS
    • EU Payment Disclosures
  • Careers
    • Employee Voices
    • Apply Online
  • Investors

    Investor Relations

    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • SEDAR Filings
      • SEDI Filings
      • Annual Reports and Proxies
      • Key Ratios
      • 8937-original
      • 8937-amended
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
      • Ownership Profile
    • Shareholder Services
      • Investor FAQs
      • 2016 PFIC Letter
      • Aralez Distribution Form 8937
      • Contact Us
  • Contact Us
  • Locations
    • Location 1
    • Location 2

SEC Filing Details

In This Section

Investor Relations

  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • SEC Filings
    • SEDAR Filings
    • SEDI Filings
    • Annual Reports and Proxies
    • Key Ratios
    • 8937-original
    • 8937-amended
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Dividend History
    • Analyst Coverage
    • Ownership Profile
  • Shareholder Services
    • Investor FAQs
    • 2016 PFIC Letter
    • Aralez Distribution Form 8937
    • Contact Us

Breadcrumb

Home // Investors // Sec filings Sec filing 10 q 10-Q //

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Nov 13, 2018
Document Date
Sep 30, 2018
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Novelion Therapeutics
Issuer
Novelion Therapeutics, Inc

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

  • Share
  • Downloads
  • Email Alerts
  • Printed Docs
  • RSS News Feeds
  • Print Page

  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS

  • Home
  • Terms of Use
  • Privacy Policy

This page is intented exclusively for U.S. audiences.

© 2019 Novelion Therapeutics Inc.
All rights reserved. AEGR/Global/167 07-14